Terms: = Breast cancer AND SMARCE1, ENSG00000073584, 6605, BAF57, Q969G3
17 results:
1. Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery system.
Hao L; Boehnke N; Elledge SK; Harzallah NS; Zhao RT; Cai E; Feng YX; Neaher S; Fleming HE; Gupta PB; Hammond PT; Bhatia SN
Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307802121. PubMed ID: 38437557
[TBL] [Abstract] [Full Text] [Related]
2. baf57 Is a Potential Determinant of Colorectal cancer Malignancy.
Suzumura H; Tsuruta M; Okabayashi K; Shigeta K; Seishima R; Ishida T; Shimada T; Asada Y; Koishikawa K; Akimoto S; Itano O; Hasegawa H; Kitagawa Y
Anticancer Res; 2021 Nov; 41(11):5445-5452. PubMed ID: 34732413
[TBL] [Abstract] [Full Text] [Related]
3. smarce1 is required for the invasive progression of in situ cancers.
Sokol ES; Feng YX; Jin DX; Tizabi MD; Miller DH; Cohen MA; Sanduja S; Reinhardt F; Pandey J; Superville DA; Jaenisch R; Gupta PB
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4153-4158. PubMed ID: 28377514
[TBL] [Abstract] [Full Text] [Related]
4. smarce1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway.
Sethuraman A; Brown M; Seagroves TN; Wu ZH; Pfeffer LM; Fan M
Breast Cancer Res; 2016 Aug; 18(1):81. PubMed ID: 27495308
[TBL] [Abstract] [Full Text] [Related]
5. Expression of baf57 in ovarian cancer cells and drug sensitivity.
Yamaguchi T; Kurita T; Nishio K; Tsukada J; Hachisuga T; Morimoto Y; Iwai Y; Izumi H
Cancer Sci; 2015 Apr; 106(4):359-66. PubMed ID: 25611552
[TBL] [Abstract] [Full Text] [Related]
6. Differential expression of genes involved in the epigenetic regulation of cell identity in normal human mammary cell commitment and differentiation.
Coradini D; Boracchi P; Oriana S; Biganzoli E; Ambrogi F
Chin J Cancer; 2014 Oct; 33(10):501-10. PubMed ID: 25223915
[TBL] [Abstract] [Full Text] [Related]
7. Identification and characterization of novel potentially oncogenic mutations in the human baf57 gene in a breast cancer patient.
Villaronga MA; López-Mateo I; Markert L; Espinosa E; Fresno Vara JA; Belandia B
Breast Cancer Res Treat; 2011 Aug; 128(3):891-8. PubMed ID: 21465167
[TBL] [Abstract] [Full Text] [Related]
8. BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription.
Harte MT; O'Brien GJ; Ryan NM; Gorski JJ; Savage KI; Crawford NT; Mullan PB; Harkin DP
Cancer Res; 2010 Mar; 70(6):2538-47. PubMed ID: 20215511
[TBL] [Abstract] [Full Text] [Related]
9. Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines.
Arriola E; Marchio C; Tan DS; Drury SC; Lambros MB; Natrajan R; Rodriguez-Pinilla SM; Mackay A; Tamber N; Fenwick K; Jones C; Dowsett M; Ashworth A; Reis-Filho JS
Lab Invest; 2008 May; 88(5):491-503. PubMed ID: 18332872
[TBL] [Abstract] [Full Text] [Related]
10. Amplification patterns of three genomic regions predict distant recurrence in breast carcinoma.
Davis LM; Harris C; Tang L; Doherty P; Hraber P; Sakai Y; Bocklage T; Doeden K; Hall B; Alsobrook J; Rabinowitz I; Williams TM; Hozier J
J Mol Diagn; 2007 Jul; 9(3):327-36. PubMed ID: 17591932
[TBL] [Abstract] [Full Text] [Related]
11. The SWI/SNF chromatin remodeling subunit baf57 is a critical regulator of estrogen receptor function in breast cancer cells.
García-Pedrero JM; Kiskinis E; Parker MG; Belandia B
J Biol Chem; 2006 Aug; 281(32):22656-64. PubMed ID: 16769725
[TBL] [Abstract] [Full Text] [Related]
12. Identification of baf57 mutations in human breast cancer cell lines.
Kiskinis E; García-Pedrero JM; Villaronga MA; Parker MG; Belandia B
Breast Cancer Res Treat; 2006 Jul; 98(2):191-8. PubMed ID: 16538531
[TBL] [Abstract] [Full Text] [Related]
13. The BRG1- and hBRM-associated factor baf57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene.
Wang L; Baiocchi RA; Pal S; Mosialos G; Caligiuri M; Sif S
Mol Cell Biol; 2005 Sep; 25(18):7953-65. PubMed ID: 16135788
[TBL] [Abstract] [Full Text] [Related]
14. Ets-2 and components of mammalian SWI/SNF form a repressor complex that negatively regulates the BRCA1 promoter.
Baker KM; Wei G; Schaffner AE; Ostrowski MC
J Biol Chem; 2003 May; 278(20):17876-84. PubMed ID: 12637547
[TBL] [Abstract] [Full Text] [Related]
15. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies.
Decristofaro MF; Betz BL; Rorie CJ; Reisman DN; Wang W; Weissman BE
J Cell Physiol; 2001 Jan; 186(1):136-45. PubMed ID: 11147808
[TBL] [Abstract] [Full Text] [Related]
16. Mortality and cancer incidence among women with a high consumption of fatty fish contaminated with persistent organochlorine compounds.
Rylander L; Hagmar L
Scand J Work Environ Health; 1995 Dec; 21(6):419-26. PubMed ID: 8824747
[TBL] [Abstract] [Full Text] [Related]
17. Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
Teller MN; Stock CC; Hellman L; Mountain IM; Bowie M; Rosenberg BJ; Boyar RM; Budinger JM
Cancer Res; 1977 Nov; 37(11):3932-8. PubMed ID: 409489
[TBL] [Abstract] [Full Text] [Related]
